Anthelmintics are drugs that work on helminths as either vermicides (by killing) or vermifuges (by expelling).
This report contains market size and forecasts of Anthelmintic Drugs in global, including the following market information:
Global Anthelmintic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anthelmintic Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anthelmintic Drugs companies in 2021 (%)
The global Anthelmintic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anthelmintic Drugs include Novartis, Pfizer, Bayer, Cipla, Sun Pharmaceutical Industries, Mankind Pharma, Johnson & Johnson and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anthelmintic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anthelmintic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anthelmintic Drugs Market Segment Percentages, by Type, 2021 (%)
Oral Drugs
Injectables
Global Anthelmintic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anthelmintic Drugs Market Segment Percentages, by Application, 2021 (%)
For Human
For Animal
Global Anthelmintic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anthelmintic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anthelmintic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anthelmintic Drugs revenues share in global market, 2021 (%)
Key companies Anthelmintic Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anthelmintic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Bayer
Cipla
Sun Pharmaceutical Industries
Mankind Pharma
Johnson & Johnson
Merck